GO:0048265 response to pain: Nociception, Genes, Functions and Research Methods

Research-grade guide for scientists and biopharma professionals

Key Takeaways

GO:0048265 response to pain describes any process that changes a cell or organism's state or activity as a result of a pain stimulus, including movement, secretion, enzyme production and gene expression.
Pain stimuli activate nociceptors, peripheral receptors sensitive to painful mechanical stimuli, extreme heat or cold, and chemical stimuli.
Valid and reliable measurement of pain intensity is essential for quantifying the response to pain in clinical and experimental settings.
Pain responses are modality-specific and can be modulated by opioid drugs, with distinct profiles for different pain modalities.
Sex and hormonal influences significantly affect responses to mechanical pressure pain in humans.
Hypervigilance to pain and healthcare experience can alter cortical responses to pain and others' suffering, highlighting central modulation of the response to pain.

Description

The Gene Ontology term GO:0048265 response to pain is defined as any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a pain stimulus. Pain stimuli cause activation of nociceptors, peripheral receptors for pain, which include receptors sensitive to painful mechanical stimuli, extreme heat or cold, and chemical stimuli. This term captures the physiological response to pain, also known as the physiological response to pain, and is a biological process that is fundamental to understanding nociception and pain perception. Researchers studying pain rely on valid and reliable tools to measure pain intensity, such as the four pain intensity rating scales that have been validated for clinical and experimental use. The response to pain is not a unitary phenomenon; it is modality-specific and can be influenced by factors such as drug response profiles, sex, hormonal status, and psychological variables like hypervigilance. Understanding the molecular and cellular mechanisms underlying the response to pain is critical for developing targeted therapies for acute and chronic pain conditions.

response to pain At A Glance

GO ID GO:0048265
GO term response to pain
Ontology biological_process
Synonym physiological response to pain
Definition Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a pain stimulus.
Major function Mediates detection of and reaction to painful mechanical, thermal, or chemical stimuli via nociceptor activation.
Related stimuli Painful mechanical stimuli, extreme heat or cold, and chemical stimuli.
Measurement tools Validated pain intensity rating scales such as visual analog scale, numerical rating scale, verbal rating scale, and faces pain scale.

What Is GO:0048265?

GO:0048265 response to pain is a biological process that encompasses any change in a cell or organism's state or activity as a result of a pain stimulus. This includes alterations in movement, secretion, enzyme production, gene expression, and other physiological activities. Pain stimuli activate nociceptors, which are peripheral receptors sensitive to painful mechanical stimuli, extreme heat or cold, and chemical stimuli. The term is synonymous with physiological response to pain and is essential for annotating genes and proteins involved in nociception and pain perception.

Why Is response to pain Important in Cell Biology?

The response to pain is a fundamental biological process that protects organisms from tissue damage and is central to clinical pain management. Dysregulation of this process contributes to acute and chronic pain conditions, and understanding its mechanisms is necessary for developing effective analgesics. Valid measurement of pain intensity is critical for assessing treatment outcomes, and tools like the four pain intensity rating scales have been validated for this purpose. Moreover, the response to pain is influenced by drug response profiles that are opioid and pain modality specific, meaning that different types of pain may require different pharmacological approaches. Sex and hormonal influences further modulate responses to mechanical pressure pain, underscoring the need for personalized pain management. Psychological factors such as hypervigilance to pain and healthcare experience can also alter cortical responses to pain, highlighting the interplay between central nervous system processing and pain perception.
Pain is a protective mechanism that alerts organisms to tissue damage and triggers withdrawal reflexes.
Chronic pain affects millions worldwide and is a leading cause of disability, making the response to pain a major research focus.
Valid and reliable pain intensity rating scales are essential for clinical trials and pain research.
Drug response profiles to experimental pain are opioid and pain modality specific, informing analgesic development.
Sex and hormonal influences on mechanical pressure pain responses necessitate sex-specific considerations in pain research.
Hypervigilance to pain is associated with altered auditory change-related cortical responses, linking attention to pain processing.
Healthcare experience affects pain-specific responses to others' suffering in the anterior insula, showing empathy-related modulation.
The Tampa Scale of Kinesiophobia has been systematically reviewed for psychometric properties in musculoskeletal pain, highlighting fear-avoidance.
The Neck Disability Index is a state-of-the-art tool for assessing disability from neck pain, a common pain condition.
The Copenhagen Hip and Groin Outcome Score (HAGOS) was developed and validated for hip and groin pain, demonstrating the need for condition-specific measures.

What Happens During response to pain?

Nociceptor Activation
In simple terms: Pain receptors in the periphery detect harmful stimuli and send signals to the brain.
The response to pain begins with the activation of nociceptors, which are peripheral receptors sensitive to painful mechanical stimuli, extreme heat or cold, and chemical stimuli. These receptors transduce noxious stimuli into electrical signals that travel along sensory neurons to the central nervous system. The activation of nociceptors is the first step in the physiological response to pain and is essential for the detection of tissue-damaging events.
Modality-Specific Processing
In simple terms: Different types of pain (e.g., heat, pressure, chemical) are processed differently by the nervous system.
The response to pain is not uniform; it is modality-specific. Drug response profiles to experimental pain have been shown to be opioid and pain modality specific, indicating that different pain modalities engage distinct neural pathways and pharmacological targets. This specificity has important implications for the development of analgesics, as a drug effective for one type of pain may not be effective for another.
Sex and Hormonal Influences
In simple terms: Men and women can respond differently to pain, and hormones play a role.
Sex differences and hormonal influences significantly affect the response to mechanical pressure pain in humans. Studies have demonstrated that pain sensitivity and tolerance can vary with hormonal status, suggesting that the response to pain is modulated by biological sex and endocrine factors. These findings highlight the need to consider sex as a biological variable in pain research and treatment.
Central Modulation and Hypervigilance
In simple terms: The brain can amplify or dampen pain signals based on attention and psychological state.
The response to pain is subject to central modulation. Hypervigilance to pain, a psychological state of heightened attention to pain-related information, is associated with altered auditory change-related cortical responses in healthy volunteers. This suggests that attentional and cortical processing mechanisms can influence how pain is perceived and responded to. Additionally, healthcare experience affects pain-specific responses to others' suffering in the anterior insula, indicating that empathy and experience can shape pain-related brain activity.
Measurement of Pain Intensity
In simple terms: Doctors and researchers use scales to measure how much pain a person feels.
Quantifying the response to pain requires valid and reliable measurement tools. Four pain intensity rating scales have been validated for use in clinical and experimental settings, including the visual analog scale, numerical rating scale, verbal rating scale, and faces pain scale. These scales allow researchers to assess pain intensity and track changes in response to interventions. The Neck Disability Index is another state-of-the-art tool for assessing disability from neck pain, a common pain condition. The Copenhagen Hip and Groin Outcome Score (HAGOS) was developed and validated according to the COSMIN checklist for hip and groin pain, demonstrating the importance of condition-specific outcome measures.

Key Genes Involved in GO:0048265 response to pain

The following genes and proteins are involved in the response to pain, based on their roles in nociception, pain modulation, and related physiological processes.
GeneMajor RoleResearch Relevance
TRPV1Transient receptor potential vanilloid 1, a nociceptor ion channel activated by heat and capsaicinTarget for analgesic development; studied in inflammatory and neuropathic pain models
SCN9AVoltage-gated sodium channel Nav1.7, essential for nociceptor excitabilityMutations cause congenital insensitivity to pain; target for pain therapeutics
OPRM1Mu-opioid receptor, mediates opioid analgesiaGenetic variants influence opioid response profiles in experimental pain
COMTCatechol-O-methyltransferase, degrades catecholaminesPolymorphisms associated with pain sensitivity and response to pain
HTR3A5-HT3 receptor, involved in serotonin-mediated pain modulationStudied in hypervigilance and central pain processing
IL6Interleukin-6, pro-inflammatory cytokineContributes to inflammatory pain and sensitization
TNFTumor necrosis factor, pro-inflammatory cytokineInvolved in neuropathic pain and central sensitization
BDNFBrain-derived neurotrophic factor, modulates synaptic plasticityImplicated in chronic pain and central sensitization
GCH1GTP cyclohydrolase 1, tetrahydrobiopterin synthesisHaplotype associated with reduced pain sensitivity
CACNA1BVoltage-gated calcium channel Cav2.2, neurotransmitter releaseTarget for ziconotide; studied in chronic pain
P2RX3P2X purinoceptor 3, ATP-gated ion channelInvolved in nociception; studied in inflammatory pain models
ASIC3Acid-sensing ion channel 3, detects tissue acidosisContributes to mechanical and chemical pain
TRPA1Transient receptor potential ankyrin 1, chemical nociceptorActivated by irritants; studied in neuropathic pain
NGFNerve growth factor, regulates nociceptor development and sensitizationTarget for anti-NGF antibodies in osteoarthritis pain
KCNQ2/3Potassium channels M-current, regulate neuronal excitabilityActivators studied for pain relief
GRIN2BNMDA receptor subunit 2B, central sensitizationInvolved in chronic pain and hyperalgesia
GABRA2GABA-A receptor subunit, inhibitory neurotransmissionModulates pain inhibition; studied in anxiety-pain comorbidity
SLC6A4Serotonin transporter, regulates serotonin levelsPolymorphisms linked to pain sensitivity and response to pain

How Is response to pain Regulated?

The response to pain is regulated at multiple levels, including peripheral sensitization, central sensitization, and descending modulation from the brainstem. Opioid and pain modality-specific drug response profiles indicate that pharmacological regulation of pain responses involves distinct receptor systems depending on the stimulus modality. Sex and hormonal influences further modulate mechanical pressure pain responses, suggesting endocrine regulation of nociceptive pathways. Psychological factors such as hypervigilance can alter cortical responses to pain, reflecting top-down regulation by attentional and emotional circuits. Healthcare experience also affects pain-specific responses in the anterior insula, indicating that learning and empathy-related processes can regulate pain processing.

response to pain and Human Disease

GeneDisease / BiologyPotential Experimental Model
SCN9ACongenital insensitivity to pain; chronic pain disordersKnockout mice, knock-in human mutations, iPSC-derived nociceptors
OPRM1Opioid response variability; addictionKnockout mice, humanized knock-in mice, cell-based receptor assays
COMTPain sensitivity; fibromyalgia; temporomandibular disorderKnockout mice, human genetic association studies, overexpression cell lines
TRPV1Inflammatory pain; neuropathic painKnockout mice, point-mutation knock-in mice, DRG neuron cultures
GCH1Pain sensitivity; neuropathic painKnockout mice, human haplotype knock-in models, overexpression cell lines
Chronic Pain Conditions
Chronic pain is a major health burden and involves maladaptive changes in the response to pain. Conditions such as chronic neck pain are assessed using tools like the Neck Disability Index, which has been state-of-the-art since 1991. Musculoskeletal pain, including hip and groin pain, is evaluated with validated instruments like the Copenhagen Hip and Groin Outcome Score (HAGOS). The Tampa Scale of Kinesiophobia has been systematically reviewed for its psychometric properties in people with musculoskeletal pain, highlighting the role of fear-avoidance in chronic pain. These conditions exemplify how dysregulated responses to pain can lead to disability and reduced quality of life.
Pain and Opioid Response
Individual differences in drug response profiles to experimental pain are opioid and pain modality specific, which has implications for personalized pain management. This means that patients may respond differently to opioids depending on the type of pain they experience, and genetic or physiological factors may influence these responses. Understanding these profiles is essential for optimizing analgesic therapy and avoiding ineffective treatments.
Sex and Hormonal Influences in Pain
Sex differences and hormonal influences on response to mechanical pressure pain in humans have been documented, indicating that men and women may require different approaches to pain management. Hormonal fluctuations, such as those occurring during the menstrual cycle, can affect pain sensitivity and tolerance. These findings underscore the importance of considering sex and hormonal status in both research and clinical practice.
Central Nervous System Processing and Pain
Hypervigilance to pain is associated with altered auditory change-related cortical responses, suggesting that central processing abnormalities may contribute to chronic pain states. Additionally, healthcare experience affects pain-specific responses to others' suffering in the anterior insula, which may have implications for empathy and pain communication in clinical settings. These central mechanisms are potential targets for psychological and neuromodulatory interventions.

From response to pain-Related Genes to Experimental Models

Research QuestionSuitable Model
Does a candidate gene cause altered pain sensitivity?Knockout mouse or rat, behavioral pain assays (e.g., von Frey, hot plate)
Does a specific point mutation affect nociceptor function?Point-mutation knock-in mouse or human iPSC-derived nociceptors
Does a human genetic variant alter pain response?Humanized knock-in mouse or transgenic overexpression in cell lines
Where is a protein expressed in pain pathways?Tagged knock-in mouse (e.g., GFP) or immunohistochemistry in DRG and spinal cord
Does overexpression of a gene enhance or reduce pain?Transgenic overexpression mouse or viral vector-mediated overexpression in vivo
What is the effect of a gene on opioid analgesia?Knockout mouse with opioid dose-response testing, cell-based receptor binding assays

How to Study the response to pain Process

MethodWhat It MeasuresTypical Application
Von Frey testMechanical withdrawal thresholdAssessing mechanical allodynia in rodent pain models
Hot plate testThermal nociceptive thresholdEvaluating thermal pain sensitivity in mice
Hargreaves testThermal withdrawal latencyStudying inflammatory and neuropathic pain
Formalin testChemical nociception (licking/biting)Assessing tonic pain and central sensitization
fMRIBrain activity in response to painHuman pain processing and modulation studies
EEGCortical responses to painHypervigilance and attention to pain
Pain intensity rating scalesSubjective pain intensityClinical and experimental pain assessment
Genetic association studiesLink between genetic variants and pain phenotypesIdentifying risk genes for chronic pain
Behavioral Pain Assays
Behavioral assays such as von Frey filaments for mechanical sensitivity, hot plate and Hargreaves tests for thermal sensitivity, and formalin test for chemical nociception are used to quantify the response to pain in animal models. These assays allow researchers to assess baseline pain sensitivity and changes after genetic or pharmacological manipulations. Validated pain intensity rating scales are used in human studies to measure subjective pain.
Electrophysiology
Electrophysiological recordings from nociceptors, dorsal root ganglia neurons, or spinal cord slices can measure neuronal excitability and synaptic transmission in response to painful stimuli. These techniques help identify ion channel and receptor contributions to the response to pain. For example, voltage-gated sodium channel currents can be recorded to study SCN9A function.
Imaging and Functional Studies
Functional magnetic resonance imaging (fMRI) and electroencephalography (EEG) can assess central processing of pain in humans. Studies have shown that hypervigilance to pain is associated with altered auditory change-related cortical responses, and healthcare experience affects pain-specific responses in the anterior insula. These methods provide insights into the brain's role in the response to pain.
Molecular and Genetic Approaches
Gene expression analysis, immunohistochemistry, and in situ hybridization can localize pain-related genes in nociceptive tissues. Genetic association studies and genome-wide association studies identify variants linked to pain sensitivity and response to pain. Drug response profiles to experimental pain can be assessed using opioid and modality-specific paradigms.

How CRISPR Can Be Used to Study GO:0048265 response to pain

Knockout

CRISPR knockout models are used to delete pain-related genes in cell lines and animal models to determine their causal role in the response to pain. For example, knocking out SCN9A or TRPV1 in mice can reveal their contribution to nociception. EDITGENE provides knockout cell models for studying pain genes in vitro, enabling researchers to assess gene function in nociceptor-like cells.

Point Mutation

Point-mutation knock-in models introduce specific human variants into pain genes to study their functional consequences. For instance, mutations in SCN9A that cause congenital insensitivity to pain can be modeled in mice or cell lines. EDITGENE offers point-mutation services to create isogenic cell lines carrying disease-associated variants in pain genes.

Knock-in

Knock-in models can be used to humanize pain genes, replace endogenous genes with human orthologs, or tag proteins for visualization. For example, a tagged knock-in of OPRM1 can track mu-opioid receptor localization in nociceptors. EDITGENE provides knock-in services for creating reporter or humanized models relevant to pain research.

Overexpression

Overexpression models are used to study the effects of increased gene dosage on pain responses. Overexpressing pain-related genes such as BDNF or NGF in cell lines or transgenic animals can reveal their role in sensitization. EDITGENE offers overexpression cell models to investigate gain-of-function effects in pain pathways.

How EDITGENE Supports response to pain Research

Researchers studying response to pain-related genes often need to determine whether a candidate gene is causally involved in nociception, whether a specific variant alters protein function, or whether overexpression or knockout changes pain sensitivity. EDITGENE provides a comprehensive suite of CRISPR-based services to address these questions, from knockout and point-mutation cell models to knock-in and overexpression systems, as well as CRISPR library screening and bioinformatics support.
Contact EDITGENE today to design your custom CRISPR model for response to pain research.

Frequently Asked Questions About response to pain

GO:0048265 response to pain is a Gene Ontology biological process term defined as any process that results in a change in state or activity of a cell or an organism as a result of a pain stimulus, including activation of nociceptors sensitive to mechanical, thermal, or chemical stimuli.
Genes involved in response to pain include TRPV1, SCN9A, OPRM1, COMT, and GCH1, among others. These genes encode ion channels, receptors, and enzymes that mediate nociceptor activation, opioid signaling, and pain sensitivity.
Response to pain is measured using validated pain intensity rating scales such as the visual analog scale, numerical rating scale, verbal rating scale, and faces pain scale in humans. In animal models, behavioral assays like von Frey and hot plate tests are used.
Sex differences and hormonal influences affect the response to mechanical pressure pain in humans, with variations in pain sensitivity and tolerance linked to hormonal status.
Drug response profiles to experimental pain are opioid and pain modality specific, meaning opioids may have different efficacy depending on the type of pain.
Hypervigilance to pain is a heightened attention to pain-related information, associated with altered auditory change-related cortical responses in healthy volunteers.
Healthcare experience affects pain-specific responses to others' suffering in the anterior insula, indicating that empathy and experience modulate pain processing.
The Tampa Scale of Kinesiophobia is a measure of fear of movement/(re)injury, and its psychometric properties have been systematically reviewed in people with musculoskeletal pain.
The Neck Disability Index is a state-of-the-art questionnaire for assessing disability from neck pain, developed and validated since 1991.
HAGOS is a patient-reported outcome measure developed and validated according to the COSMIN checklist for assessing hip and groin pain and disability.

Conclusion

The response to pain (GO:0048265) is a complex biological process that involves nociceptor activation, modality-specific processing, sex and hormonal influences, and central modulation. Valid measurement tools and an understanding of drug response profiles are essential for both research and clinical management of pain. Dysregulation of this process contributes to chronic pain conditions, and psychological factors such as hypervigilance and healthcare experience can further shape pain responses. Continued research into the genetic and molecular mechanisms of the response to pain is critical for developing more effective and personalized pain therapies.

References

  1. 1. Ferreira-Valente MA et al.. 2011. Validity of four pain intensity rating scales.. Pain 152(10):2399-2404 PMID: 21856077
  2. 2. Dupuis F et al.. 2023. The Tampa Scale of Kinesiophobia: A Systematic Review of Its Psychometric Properties in People With Musculoskeletal Pain.. Clin J Pain 39(5):236-247 PMID: 36917768
  3. 3. Vernon H. 2008. The Neck Disability Index: state-of-the-art, 1991-2008.. J Manipulative Physiol Ther 31(7):491-502 PMID: 18803999
  4. 4. Otsuru N et al.. 2022. Auditory change-related cortical response is associated with hypervigilance to pain in healthy volunteers.. Eur J Pain 26(2):349-355 PMID: 34528347
  5. 5. Kindler LL et al.. 2011. Drug response profiles to experimental pain are opioid and pain modality specific.. J Pain 12(3):340-51 PMID: 21146469
  6. 6. Corradi-Dell'Acqua C et al.. 2023. Healthcare experience affects pain-specific responses to others' suffering in the anterior insula.. Hum Brain Mapp 44(17):5655-5671 PMID: 37608624
  7. 7. Kowalczyk WJ et al.. 2010. Sex differences and hormonal influences on response to mechanical pressure pain in humans.. J Pain 11(4):330-42 PMID: 19853526
  8. 8. Thorborg K et al.. 2011. The Copenhagen Hip and Groin Outcome Score (HAGOS): development and validation according to the COSMIN checklist.. Br J Sports Med 45(6):478-91 PMID: 21478502
Contact Us
*
*
*
*
How did you hear about us: